The levels of MDA in rats with diabetes induced via STZ that subsequently received liraglutide treatment were lowered (p < 0.05), whereas SOD (p < 0.01) and GPx (p < 0.05) activities were elevated (Figure 3). This evidence concerns the gene SOD1 and diabetes mellitus.